Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 44 Colorectal Neoplasms 22 Breast Neoplasms 22 Stomach Neoplasms 21 Neoplasms 18 Esophageal Squamous Cell Carcinoma 12 Neoplasm Metastasis 11 Nasopharyngeal Carcinoma 11 Lung Neoplasms 11 Rectal Neoplasms 9 Colonic Neoplasms 8 Pancreatic Neoplasms 7 Uterine Cervical Neoplasms 6 Esophageal Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Ovarian Neoplasms 5 Osteosarcoma 5 Brain Neoplasms 5 Small Cell Lung Carcinoma 4 Recurrence 4 Glioblastoma 4 Gastrointestinal Neoplasms 4 Precision Cell Immunotherapy 3 Melanoma 3 Lymphoma, Non-Hodgkin 3 Lymphoma 3 Head and Neck Neoplasms 3 Gastrointestinal Diseases 3 Digestive System Neoplasms 3 Carcinoma, Ovarian Epithelial 3

Interventions

pyrotinib 1 Trastuzumab 1 Drug Therapy 1 Docetaxel 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × HER2-positive Metastatic Breast Cancer × Drug Therapy × Clear all

NCT05188495 2022-01-12

HELP

Peking University Cancer Hospital & Institute

HER2-positive Metastatic Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡